ecancermedicalscience

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Editor-in-Chief: Dr Eduardo Cazap, MD PhD (President SLACOM)

ISSN: 1754-6605

Submit article

724-pre-operative-axillary-staging-should-core-biopsy-be-preferred-to-fine-needle-aspiration-cytology

Clinical Study: Pre-operative axillary staging: should core biopsy be preferred to fine needle aspiration cytology?

Raghavan Vidya, Fahad Mujtaba Iqbal, Bernadette Bickley

7 Mar 2017

https://doi.org/10.3332/ecancer.2017.724

Abstract | Full Article | PDF

715-bone-metastasis-risk-factors-in-breast-cancer

Review: Bone metastasis risk factors in breast cancer

Catarina Pulido, Inês Vendrell, Arlindo R Ferreira, Sandra Casimiro, André Mansinho, Irina Alho, Luís Costa

24 Jan 2017

https://doi.org/10.3332/ecancer.2017.715

Abstract | Full Article | PDF

703-biomarkers-come-of-age-pd1-in-the-frontline-and-cell-cycle-therapy-swells-the-ranks-of-personalised-therapy-in-the-european-society-of-medical-oncology-esmo-congress-copenhagen-7-10-october-2016

Conference Report: Biomarkers come of age: PD1 in the frontline and cell cycle therapy swells the ranks of personalised therapy in the European Society of Medical Oncology (ESMO) congress, Copenhagen, 7–10 October 2016

Will Davies

16 Dec 2016

https://doi.org/10.3332/ecancer.2016.703

Abstract | Full Article | PDF

702-the-neutrophil-to-lymphocyte-ratio-a-narrative-review

Review: The neutrophil-to-lymphocyte ratio: a narrative review

Sara Socorro Faria, Paulo César Fernandes Jr, Marcelo José Barbosa Silva, Vladmir C Lima, Wagner Fontes, Ruffo Freitas-Junior, Agda Karina Eterovic, Patrice Forget

12 Dec 2016

https://doi.org/10.3332/ecancer.2016.702

Abstract | Full Article | PDF

697-radiation-induced-breast-angiosarcoma-a-case-report

Case Report: Radiation-induced breast angiosarcoma: a case report

Sara Tato-Varela, Rosa Albalat-Fernández, Sara Pabón-Fernández, Diego Núñez-García, Manolo La Calle-Marcos

29 Nov 2016

https://doi.org/10.3332/ecancer.2016.697

Abstract | Full Article | PDF | Spanish

691-cancer-immunotherapy-from-the-lab-to-clinical-applications-potential-impact-on-cancer-centres-organisation

Conference Report: Cancer Immunotherapy: from the lab to clinical applications. Potential impact on cancer centres’ organisation

Linda Cairns, Sandrine Aspeslagh, Andrea Anichini, Jon Amund Kyte, Christian Blank, Paolo Ascierto, Nicolle Rekers, Per Thor Straten, Ahmad Awada

9 Nov 2016

https://doi.org/10.3332/ecancer.2016.691

Abstract | Full Article | PDF

683-innovations-that-reach-the-patient-early-health-technology-assessment-and-improving-the-chances-of-coverage-and-implementation

Special Issue: Innovations that reach the patient: early health technology assessment and improving the chances of coverage and implementation

WH van Harten, VP Retèl

28 Oct 2016

https://doi.org/10.3332/ecancer.2016.683

Abstract | Full Article | PDF

677-veror-radiotherapy-for-low-burden-cancer-789-patients-with-957-lesions

Research: VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions

R Orecchia, A Surgo, M Muto, A Ferrari, G Piperno, MA Gerardi, S Comi, C Garibaldi, D Ciardo, A Bazani, F Golino, F Pansini, C Fodor, P Romanelli, D Maestri, V Scroffi, S Mazza, BA Jereczek-Fossa

29 Sep 2016

https://doi.org/10.3332/ecancer.2016.677

Abstract | Full Article | PDF